FDA

Study: AI could cut medical device recalls

A Management Science study proposes a human-plus-algorithm approach to help the FDA prioritize higher-risk medical device reviews. Simulations show a 40.5% workload reduction, a 32.9% recall-rate improvement, and up to $1.7B in annual savings.